According to WHO estimates, more than 180 million people suffer from diabetes mellitus worldwide and this number could double within 15 years. Normal function of the brain is dependent on continuous supply of glucose. In hypoglycemia, production of counterregulatory hormones (glucagon, epinephrine, growth hormone, and cortisol) increases, the sympathetic system becomes stimulated, and features of neuroglycopenia appear in order to save the homeostasis. Hypoglycemia is an alarming, actually life-threatening condition, but the exposures to chronic hyperglycemia have a more detrimental effect on the brain than recurrent exposure to severe hypoglycemia. The active neural response to hyperglycemia induces changes in gene expression and function. The first steps against hyperosmolality are initially adaptive, but later hyperactivation of the hypothalamic magnocellular neurosecretory cells leads to their structural damage. Changes in hippocampal gene transcription are partially implicated in the deterioration of declarative memory. Neurologically passive shunting of excess glucose through alternative cellular metabolic pathways induces atherogenic, vascular lesions, free radicals, leukoencephalopathy and atrophy of the brain, thus leading to cognitive deficits. In physiological conditions insulin has a neuroprotective effect. However, insulin resistance in the central nervous system correlates with insulin resistance in the periphery. Loss of responsiveness to insulin could render neurons more susceptible to neurotoxic insults, the protective effect of insulin diminishes, and apoptosis, neurodegeneration and the resultant cognitive decline are all increased in insulin-resistant patients. Some unclear relations appear between diabetes mellitus and Alzheimer’s disease. Diabetic patients with APOE-4 gene have an increased risk for Alzheimer’s disease. Prevalence of depression is higher in patients with diabetes mellitus and in turn, depression is a risk factor for diabetes mellitus. Simultaneous presence of depression and diabetes mellitus tends to worsen the course of both.
WHO Media centre.http://www.who.int/mediacentre/factsheets/fs312/en/index.html (29. 09. 2007)
Van der Berg, E., Kessels, R. P. C., de Haan, E. H. F. et al.: Type 2 diabetes, cognitive function and dementia: vascular and metabolic determinants. Drugs Today, 2006, 42 , 741–754.
Haan E. H. F. , 'Type 2 diabetes, cognitive function and dementia: vascular and metabolic determinants ' (2006 ) 42 Drugs Today : 741 -754 .
Briscoe, V. J., Davis, S. N.: Hypoglycemia in Type 1 and Type 2 Diabetes: Physiology, Pathophysiology, and Management. Clin. Diabet., 2006, 24 , 115–121.
Davis S. N. , 'Hypoglycemia in Type 1 and Type 2 Diabetes: Physiology, Pathophysiology, and Management ' (2006 ) 24 Clin. Diabet. : 115 -121 .
Kaplan, P. W.: The EEG in metabolic encephalopathy and coma. J. Clin. Neurophysiol., 2004, 21 , 307–318.
Kaplan P. W. , 'The EEG in metabolic encephalopathy and coma ' (2004 ) 21 J. Clin. Neurophysiol. : 307 -318 .
The Diabetes Control and Complications Trial / Epidemiology of Diabetes Interventions and Complications Study Research Group: Long-term effect of diabetes and its treatment on cognitive function. N. Engl. J. Med., 2007, 356 , 1842–1852.
'Long-term effect of diabetes and its treatment on cognitive function ' (2007 ) 356 N. Engl. J. Med. : 1842 -1852 .
Iino, K., Yoshinari, M., Yoshizumi, H. et al.: Normal pressure hydrocephalus in diabetic patients with recurrent episodes of hypoglycemic coma. Diab. Research Clin. Pract., 2000, 47 , 105–110.
Yoshizumi H. , 'Normal pressure hydrocephalus in diabetic patients with recurrent episodes of hypoglycemic coma ' (2000 ) 47 Diab. Research Clin. Pract. : 105 -110 .
Klein, J. P., Waxman, S. G.: The brain in diabetes: molecular changes in neurons and their implications for end-organ damage. Lancet Neurol., 2003, 2 , 548–554.
Waxman S. G. , 'The brain in diabetes: molecular changes in neurons and their implications for end-organ damage ' (2003 ) 2 Lancet Neurol. : 548 -554 .
Somogyi, A., Simon, K.: Fokozott kardiovaszkuláris kockázat diabetesben. (Increased cardiovascular risk in diabetes) (In Hungarian). Diabet. Hung., 2002, 10 , 125–130.
Simon K. , 'Fokozott kardiovaszkuláris kockázat diabetesben. (Increased cardiovascular risk in diabetes) (In Hungarian) ' (2002 ) 10 Diabet. Hung. : 125 -130 .
Toth, C., Schmidt, A. M., Tour, U. I. et al.: Diabetes, leukoencephalopathy and rage. Neurobiol. Dis., 2006, 23 , 445–461.
Tour U. I. , 'Diabetes, leukoencephalopathy and rage ' (2006 ) 23 Neurobiol. Dis. : 445 -461 .
Winkler G.: A diabetes mellitus szövődményei. (Complications of diabetes mellitus) In: A belgyógyászat alapjai. (The Basics of Internal Medicine) (In Hungarian) Ed.: Tulassay Zsolt. Medicina Könyvkiadó, Budapest. 2007, pp. 1541–1569.
Winkler G. , '', in A belgyógyászat alapjai. (The Basics of Internal Medicine) , (2007 ) -.
Gregg, E. W., Yaffe, K., Cauley, J. A. et al.: Is diabetes associated with cognitive impairment and cognitive decline among older women? Arch. Intern. Med., 2000, 160 , 174–180.
Cauley J. A. , 'Is diabetes associated with cognitive impairment and cognitive decline among older women? ' (2000 ) 160 Arch. Intern. Med. : 174 -180 .
Sommerfield, A. J., Deary, I. J., Frier, B. M.: Acute hyperglycemia alters mood state and impairs cognitive performance in people with Type 2 Diabetes. Diabet. Care, 2004, 27 , 2335–2340.
Frier B. M. , 'Acute hyperglycemia alters mood state and impairs cognitive performance in people with Type 2 Diabetes ' (2004 ) 27 Diabet. Care : 2335 -2340 .
Cox, D. J., Kovatchev, B. P., Gonder-Frederick, L. A. et al.: Relationships between hyperglycemia and cognitive performance among adults with type 1 and type 2 diabetes. Diabet. Care, 2005, 28 , 71–77.
Gonder-Frederick L. A. , 'Relationships between hyperglycemia and cognitive performance among adults with type 1 and type 2 diabetes ' (2005 ) 28 Diabet. Care : 71 -77 .
Brands, A. M. A., Kessels, R. P. C., Hoogma, R. P. L. et al.: Cognitive performance, psychological well-being, and brain magnetic resonance imaging in older patients with Type 1 Diabetes. Diabetes, 2006, 55 , 1800–1806.
Hoogma R. P. L. , 'Cognitive performance, psychological well-being, and brain magnetic resonance imaging in older patients with Type 1 Diabetes ' (2006 ) 55 Diabetes : 1800 -1806 .
Hagemann, R., Sartory, G., Hader, C. et al.: Mood and cognitive function in elderly diabetic patients living in care facilities. Dement. Geriatr. Cogn. Disord., 2005, 19 , 369–375.
Hader C. , 'Mood and cognitive function in elderly diabetic patients living in care facilities ' (2005 ) 19 Dement. Geriatr. Cogn. Disord. : 369 -375 .
Diamant, M.: Brain insulin signalling in the regulation of energy balance and peripheral metabolism. Ideggyógy. Sz., 2007, 60 , 97–108.
Diamant M. , 'Brain insulin signalling in the regulation of energy balance and peripheral metabolism ' (2007 ) 60 Ideggyógy. Sz. : 97 -108 .
Cole, A. R., Astell, A., Green, C. et al.: Molecular connexions between dementia and diabetes. Neurosci. Biobehav. Rev., 2007, 31 , 1046–1063.
Green C. , 'Molecular connexions between dementia and diabetes ' (2007 ) 31 Neurosci. Biobehav. Rev. : 1046 -1063 .
Okereke, O., Hankinson, S. E., Hu, F. B. et al.: Plasma C peptide level and cognitive function among older women without diabetes mellitus. Arch. Intern. Med., 2005, 165 , 1651–1656.
Hu F. B. , 'Plasma C peptide level and cognitive function among older women without diabetes mellitus ' (2005 ) 165 Arch. Intern. Med. : 1651 -1656 .
Castillo-Quan, J. I., Herrera-González, A., Pérez-Osorio, J. M.: Insulin-cortisol interaction in depression and other neurological diseases: An alternative hypothesis. Psychoneuroendocrinology, 2007, 32 , 854–855.
Pérez-Osorio J. M. , 'Insulin-cortisol interaction in depression and other neurological diseases: An alternative hypothesis ' (2007 ) 32 Psychoneuroendocrinology : 854 -855 .
Llorente, M. D., Urrutia, V.: Diabetes, psychiatric disorders, and the metabolic effects of antipsychotic medications. Clin. Diabet., 2006, 24 , 18–24.
Urrutia V. , 'Diabetes, psychiatric disorders, and the metabolic effects of antipsychotic medications ' (2006 ) 24 Clin. Diabet. : 18 -24 .
Luchsinger, J. A., Reitz, C., Patel, B. et al.: Relation of diabetes to mild cognitive impairment. Arch. Neurol., 2007, 64 , 570–575.
Patel B. , 'Relation of diabetes to mild cognitive impairment ' (2007 ) 64 Arch. Neurol. : 570 -575 .
Watari, K., Letamendi, A., Eldkerin-Thompson, V. et al.: Cognitive function in adults with type 2 diabetes and major depression. Arch. Clin. Neuropsychol., 2006, 21 , 787–796.
Eldkerin-Thompson V. , 'Cognitive function in adults with type 2 diabetes and major depression ' (2006 ) 21 Arch. Clin. Neuropsychol. : 787 -796 .
Lustman, P. J., Clouse, R. E.: Depression in diabetic patients. The relationship between mood and glycemic control. J. Diabet. Comp., 2005, 19 , 113–122.
Clouse R. E. , 'Depression in diabetic patients. The relationship between mood and glycemic control ' (2005 ) 19 J. Diabet. Comp. : 113 -122 .